10-18140454-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_201596.3(CACNB2):c.-283C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0964 in 151,970 control chromosomes in the GnomAD database, including 920 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.096 ( 920 hom., cov: 33)
Consequence
CACNB2
NM_201596.3 5_prime_UTR_premature_start_codon_gain
NM_201596.3 5_prime_UTR_premature_start_codon_gain
Scores
1
1
Clinical Significance
Conservation
PhyloP100: -1.31
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 10-18140454-C-T is Benign according to our data. Variant chr10-18140454-C-T is described in ClinVar as [Benign]. Clinvar id is 1291527.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.271 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNB2 | NM_201596.3 | c.-283C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/14 | ENST00000324631.13 | NP_963890.2 | ||
CACNB2 | NM_201596.3 | c.-283C>T | 5_prime_UTR_variant | 1/14 | ENST00000324631.13 | NP_963890.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631 | c.-283C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/14 | 1 | NM_201596.3 | ENSP00000320025.8 | |||
CACNB2 | ENST00000324631 | c.-283C>T | 5_prime_UTR_variant | 1/14 | 1 | NM_201596.3 | ENSP00000320025.8 |
Frequencies
GnomAD3 genomes AF: 0.0963 AC: 14627AN: 151856Hom.: 912 Cov.: 33
GnomAD3 genomes
AF:
AC:
14627
AN:
151856
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0964 AC: 14657AN: 151970Hom.: 920 Cov.: 33 AF XY: 0.101 AC XY: 7525AN XY: 74272
GnomAD4 genome
AF:
AC:
14657
AN:
151970
Hom.:
Cov.:
33
AF XY:
AC XY:
7525
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
597
AN:
3464
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at